A perfect combing of the process of chemotherapy and immunotherapy may found useful in eradicating reemergence of cancer cells, a new study shows. Researchers associate with Virginia Commonwealth University (VCU) discovered that immunotherapy posses the ability to destroy the dormant tumor growth that may have survived the chemotherapy process.
The study revealed that there were 2 types of cancer cells that were not eliminated by chemotherapy and also resist its recurring process. However it was found that a vast number of these dormant cells were destroyed during the process of immunotherapy.
“Immunotherapy is just involves timing,” said Masoud H. Manjili, co-author of the study. He was from Department of Microbiology and Immunology in VCU School of Medicine. “The most opted time to apply immunotherapy for cancer prevention is at the stage of tumor dormancy, where it prevents the disease to advance further”.
The research appears in the Journal of Leukocyte Biology.